A guide to ferroptosis in cancer
Molecular Oncology · 2024-06 · 18 (6) · 1378-1396
DOI: 10.1002/1878-0261.13649 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Oncology, online erschienen am 08.04.2024. Verfasst von Fatma Isil Yapici und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany. Hauptthemen laut MEDLINE: Ferroptosis, Neoplasms, Tumor Microenvironment. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 169 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Berlin Center for Machine Learning, Ministry of Culture and Science of the State of Northrhine Westphalia, Germany.
Abstract (Originalsprache)
Ferroptosis is a newly identified iron‐dependent type of regulated cell death that can also be regarded as death caused by the specific collapse of the lipid antioxidant defence machinery. Ferroptosis has gained increasing attention as a potential therapeutic strategy for therapy‐resistant cancer types. However, many ferroptosis‐inducing small molecules do not reach the pharmacokinetic requirements for their effective clinical use yet. Nevertheless, their clinical optimization is under development. In this review, we summarize the current understanding of molecular pathways regulating ferroptosis, how cells protect themselves from the induction of ferroptotic cell death, and how a better understanding of cancer cell metabolism can represent vulnerabilities for ferroptosis‐based therapies. Lastly, we discuss the context‐dependent effect of ferroptosis on various cell types within the tumor microenvironment and address controversies on how tissue ferroptosis might impact systemic cancer immunity in a paracrine manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Genomics, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.
- CECAD Cluster of Excellence, University of Cologne, Germany.
- Center for Molecular Medicine Cologne, Faculty of Medicine and University Hospital Cologne, University of Cologne, Germany.
ORCID-Profile: Christina M Bebber, Silvia von Karstedt
Förderung
- Deutsche Forschungsgemeinschaft
- Berlin Center for Machine Learning
- Ministry of Culture and Science of the State of Northrhine Westphalia, Germany
- Center for Molecular Medicine Cologne (CMMC)
Zitieren
APA
Yapici, F. I., Bebber, C. M., & von Karstedt, S. (2024). A guide to ferroptosis in cancer. Molecular Oncology, 18(6), 1378-1396. https://doi.org/10.1002/1878-0261.13649
Vancouver
Yapici FI, Bebber CM, von Karstedt S. A guide to ferroptosis in cancer. Molecular Oncology. 2024;18(6):1378-1396. doi:10.1002/1878-0261.13649
BibTeX
@article{Yapici2024,
author = {Yapici, Fatma Isil and Bebber, Christina M and von Karstedt, Silvia},
title = {A guide to ferroptosis in cancer},
journal = {Molecular Oncology},
year = {2024},
volume = {18},
number = {6},
pages = {1378--1396},
doi = {10.1002/1878-0261.13649}
}
EUVIMED